Inventor

ROMANI LUIGINA

IT11 patents

⚠️ This page may combine multiple inventors who share the name “ROMANI LUIGINA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SCICLONE PHARMACEUTICALS INT LTD

2 patents

US11524056B2Dec 13, 2022

Thymosin alpha 1 for use in treatment of cystic fibrosis

SCICLONE PHARMACEUTICALS INT LTD1 citations69

US10478474B2Nov 19, 2019

Thymosin alpha 1 for use in treatment of cystic fibrosis

SCICLONE PHARMACEUTICALS INT LTD2 citations69

RASI GUIDO

2 patents

US8389680B2Mar 5, 2013

Treatment of Aspergillus infections with alpha thymosin peptides

RASI GUIDO0 citations41

US8207294B2Jun 26, 2012

Treatment of Aspergillus infections with alpha thymosin peptides

RASI GUIDO1 citations41

KOPF MANFRED

1 patent

US8586035B2Nov 19, 2013

Use of IL-23 antagonists for treatment of infection

KOPF MANFRED5 citations65

SCICLONE PHARMACEUTICALS INT SG PTE LTD

1 patent

US12083165B2Sep 10, 2024

Thymosin alpha 1 for use in treatment of cystic fibrosis

SCICLONE PHARMACEUTICALS INT SG PTE LTD0 citations56

TECNOGEN SPA

1 patent

US7910092B2Mar 22, 2011

Use of the long pentraxin PTX3 for the prevention or treatment of viral diseases

TECNOGEN SPA2 citations51

SIGMA TAU IND FARMACEUTI

1 patent

US8022036B2Sep 20, 2011

Use of thymosin alpha 1 for the treatment of immunological diseases

SIGMA TAU IND FARMACEUTI0 citations48

CARMINATI PAOLO

1 patent

US8268304B2Sep 18, 2012

Use of the long pentraxin PTX3 for the prevention or treatment of viral diseases

CARMINATI PAOLO0 citations44

ROMANI LUIGINA

1 patent

US8337828B2Dec 25, 2012

Use of thymosin alpha 1, alone or in combination with PTX3 or ganciclovir, for the treatment of cytomegalovirus infection

ROMANI LUIGINA0 citations42

Universita′ degli Studi di Perugia

1 patent

US10751322B2Aug 25, 2020

Indole-3-aldehyde for treating dysreactive immune disorders

Universita′ degli Studi di Perugia0 citations33